Nivelles, Belgium — March 17, 2026 — Quantoom Biosciences today announced a new distribution partnership with Europa Biosite, a leading and fast-growing European life-science distributor. The agreement expands access to Quantoom’s research RNA production solutions for scientists across Europe.

Under the partnership, Europa Biosite will distribute Quantoom’s Ntensify ® mano and Ntensify® micro technology, designed for rapid and qualitative RNA production in research settings. The collaboration is expected to broaden to include Ncapsulate® LNP formulation kits as these technologies become available to the research market.

Quantoom Biosciences’ mission is to accelerate the future of medicine by empowering rapid development of RNA-LNP based therapeutics. By combining Quantoom’s streamlined production platform with Europa Biosite’s strong regional presence and established customer network, the partnership supports growing demand for accessible RNA and RNA-LNP research tools.

“Europa Biosite has built an impressive reputation for connecting innovative technologies with leading research laboratories across Europe,” said José Castillo, CEO of Quantoom Biosciences. “By joining forces, we make high-quality RNA production and formulation tools more accessible, helping researchers accelerate the development of next-generation RNA applications.”

Europa Biosite is recognized for building high-quality supplier relationships and delivering advanced reagents and technologies to academic, biotech, and pharmaceutical laboratories throughout Europe. The addition of Quantoom’s RNA production portfolio strengthens Europa Biosite’s offering in the rapidly expanding RNA research field.

Together, the companies aim to equip researchers with integrated solutions that reduce technical barriers and accelerate progress in RNA science.